These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6330398)

  • 41. [Serum angiotensin converting enzyme activity in patients with untreated essential arterial hypertension].
    Huskić J; Kulenović H
    Med Arh; 1996; 50(3-4):77-80. PubMed ID: 9601758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse.
    Huang W; Gallois Y; Bouby N; Bruneval P; Heudes D; Belair MF; Krege JH; Meneton P; Marre M; Smithies O; Alhenc-Gelas F
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13330-4. PubMed ID: 11687636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum angiotensin-converting enzyme increases during hemodialysis. Evidence for injury of the pulmonary vascular endothelium?
    Nielsen AH; Knudsen F; Kristensen SD
    Nephron; 1985; 40(1):100-3. PubMed ID: 2987714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease.
    Wetmore JB; Johansen KL; Sen S; Hung AM; Lovett DH
    Hum Genet; 2006 Sep; 120(2):201-10. PubMed ID: 16791616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and survival in a cohort of chronic hemodialysis patients.
    Higashiuesato Y; Tana T; Tozawa M; Iseki C; Iseki K; Fukiyama K; Takishita S
    Clin Nephrol; 2002 Nov; 58(5):370-5. PubMed ID: 12425488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of the polymorphism of angiotensinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan.
    Chang HR; Cheng CH; Shu KH; Chen CH; Lian JD; Wu MY
    J Chin Med Assoc; 2003 Jan; 66(1):51-6. PubMed ID: 12728975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Angiotensin I-converting enzyme gene polymorphism and renal disease].
    Nakai K; Itoh C; Nakai K; Saito F; Ninomiya K; Sato M; Sudo M
    Rinsho Byori; 1997 Nov; 45(11):1067-71. PubMed ID: 9396347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Some Aspects of the Renin-Angiotensin-System in Hemodialysis Patients.
    Malik U; Raizada V
    Kidney Blood Press Res; 2015; 40(6):614-22. PubMed ID: 26618349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Parving HH
    Diabetes; 1995 May; 44(5):489-94. PubMed ID: 7729604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TNF alpha-308 genotype and renin-angiotensin system in hemodialysis patients: an effect on inflammatory cytokine levels?
    Genctoy G; Altun B; Kiykim AA; Arici M; Erdem Y; Cağlarg M; Yasavul U; Turgan C; Cağlar S
    Artif Organs; 2005 Feb; 29(2):174-8. PubMed ID: 15670287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.
    Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P
    Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
    Nikzamir A; Nakhjavani M; Esteghamati A; Rashidi A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1274-7. PubMed ID: 17986476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake?
    Heine GH; Ulrich C; Köhler H; Girndt M
    Am J Nephrol; 2004; 24(4):461-8. PubMed ID: 15331890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphism of angiotensin converting enzyme in hemodialysis patients--association with cardiovascular morbidity.
    Tošić JS; Đurić Ž; Popović J; Buzadžić I; Dimković S; Dimković N
    Med Pregl; 2014; 67(9-10):297-304. PubMed ID: 25546976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients.
    Zsom M; Fülöp T; Zsom L; Baráth A; Maróti Z; Endreffy E
    Hemodial Int; 2011 Oct; 15(4):501-8. PubMed ID: 22111818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Significance of elevated serum ACE in pneumology].
    Gustin M; Radermecker M
    Poumon Coeur; 1982; 38(6):339-45. PubMed ID: 6298762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus.
    Freire MB; van Dijk DJ; Erman A; Boner G; Warram JH; Krolewski AS
    Nephrol Dial Transplant; 1998 Oct; 13(10):2553-8. PubMed ID: 9794558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.